Roche, Bristol-Myers Melanoma Therapies Boost Survival
238 views · Published 6 June 2011 · 2:05 · Indexed 20 November 2026
Channel: Bloomberg Originals · 2011 · Entertainment
June 6 (Bloomberg) -- An experimental drug from Roche Holding AG and Daiichi Sankyo Co. prolonged the lives of patients with melanoma in a study, a result that may lead to a second new treatment to fight deadly skin cancer. Shannon Pettypiece reports from the American Society of Clinical Oncology meeting in Chicago on Bloomberg Television's "In the Loop." (Source: Bloomberg)
More from this channel
-
3:30
Market Close 6.4 - Bloomberg
-
0:17
Pens Tie Stanley Cup Series - Bloomberg
-
0:35
Hardware Price Too High - Activision - Bloomberg
-
0:31
FDIC Seeks Citigroup Shares-Up - WSJ - Bloomberg
-
0:44
Bank Have More Accounting Leeway - Bloomberg
-
0:32
Lakers Beat Magic 100-75 - Bloomberg
-
0:30
Johnson Wins 300th Game - Bloomberg
-
1:13
GM Expects To Sell Saturn To Penske Automotive - Bloomberg